Kabra Drugs Ltd. - KABRADG, 524322 corporate action history

See all forthcoming Bonus and Splits

See all forthcoming Bonus and Splits

Ex-Date	Purpose	Notes
02 Sep 2025	Others	Inter-alia, to consider 1. Directors Report and Corporate Governance Report for the financial year 2024 -25. 2. Draft Notice calling the AGM. 3. Other business matters.
14 Aug 2025	Quarterly Results	-
06 Aug 2025	Others	Inter-alia, to consider 1. To discusses about expansion and new business opportunities. 2. To Broad base the board and to bring in new technical people. 3. Other business matters.
18 Jun 2025	Others	Inter-alia, to consider 1. New acquisition. 2. New drug license for a Chennai office. 3. Diversification by creating new subsidiary. 4. Other business matters.
30 May 2025	Audited Results	-
14 Feb 2025	Quarterly Results	-
14 Nov 2024	Quarterly Results	-
04 Nov 2024	Others	-
14 Aug 2024	Quarterly Results	-
12 Jul 2024	Others	Inter alia, 1. To consider and change the registered office of the Company within the local limits of city where the registered office of the company is presently situated;

See all Rights History for Kabra Drugs Ltd.